Likewise, chronic metformin treatment on 3xTg-AD mice exacerbates amyloid pathology, increasing both amyloid plaques and Aß oligomers, and promotes tau phosphorylation and GSK3α and GSK3ß expression [157]. Here, MAPT is linked to Alzheimer disease.